Drug Resistance
New findings from S. Kohno and co-researchers in the area of drug resistance described
Published in Anti-Infectives Week, January 28th, 2008
In this recent article published in the Journal of Antimicrobial Chemotherapy, scientists in the United States conducted a study "To compare the efficacy and safety of linezolid and vancomycin for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Japan. Patients with nosocomial pneumonia, complicated skin and soft-tissue infections or sepsis caused by MRSA were randomized to receive linezolid (600 mg every 12 h) or vancomycin (1 g every 12 h)."
"One hundred patients received linezolid and 51 received vancomycin with outcomes evaluated at the end of therapy (EOT) and at the follow-up (FU), 7-14 days later. At EOT, clinical success...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2008-01-28)
More Articles from Anti-Infectives Week
- Antimicrobials
Agion Technologies Expands Global Regulatory Approval Portfolio with Approvals by US EPA, NSF, and EU EFSA - Cancer
New cancer data have been reported by T.P.H. Buys and co-authors - Cancer
Research in the area of cancer reported from Z. Shi and colleagues - Drug Resistance
Data on drug resistance described by researchers at University of Costa Rica - Drug Resistance
New drug resistance research has been reported by M.A. Borg et al - Drug Resistance
New drug resistance study findings have been reported from S.G. Fraga et al - More from this issue of Anti-Infectives Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
